Sep 27, 2019 –
The new AUC for gastrointestinal (GI) transit scintigraphy addresses several clinical scenarios for GI motility. To improve utilization and guide providers to use GI transit scintigraphy for motility in a more appropriate way, the Society of Nuclear
|
Sep 9, 2017 –
The new AUC for somatostatin receptor PET imaging addresses several clinical scenarios for neuroendocrine tumors. To improve utilization and guide providers to use somatostatin receptor PET imaging for neuroendocrine tumors in a more appropriate way,
|
Jun 9, 2017 –
The new AUC for FDG PET/CT addresses several clinical scenarios for restaging and response assessment of malignant disease. To improve utilization and guide providers across specialties to use FDG-PET, the Society of Nuclear Medicine and Molecular Im
|
Jun 5, 2017 –
The AUC for Hepatobiliary Scintigraphy addresses several clinical scenarios for abdominal pain. To improve utilization and guide providers across specialties to use HIDA, the Society of Nuclear Medicine and Molecular Imaging (SNMMI), the European Ass
|
Jan 20, 2017 –
The AUC for Ventilation–Perfusion Imaging addresses several clinical scenarios for pulmonary embolism. To promote appropriate utilization and guide providers across specialties to use V/Q Scan, the Society of Nuclear Medicine and Molecular Imaging (S
|
Jan 20, 2017 –
The AUC for Bone Scintigraphy addresses several clinical scenarios for metastatic bone disease, across a variety of oncologic indications. To improve utilization and guide providers to use bone scan in a more appropriate way, the Society of Nuclear M
|
Jan 28, 2013 –
While elevated beta amyloid plaques are one of the defining pathologic features of Alzheimer’s, many elderly people with normal cognition also have elevated levels of these plaques, as do people with conditions other than Alzheimer’s dementia. Theref
|
Jun 7, 2024 –
SNMMI and the Alzheimer’s Association and their designated experts, collaborated to update this Appropriate Use Criteria (AUC) document. The primary goal of this AUC is to assist clinicians in identifying clinical scenarios in which amyloid or tau P
|
|
|
Jun 7, 2024 –
This document describes the appropriate doses for radiopharmaceutical administration in the pediatric population. These recommendations should be utilized to safely guide nuclear medicine physicians in the amount of administered activity being ordere
|
Jun 7, 2024 –
The purpose of this document is to guide nuclear medicine practitioners in making recommendations, performing, interpreting, and reporting results of PET imaging of the brain using 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG).
|
Jun 7, 2024 –
This guideline provides general information about indications and protocols for hybrid [18F]FDG PET imaging in inflammation and infection in the adult population.
|
|
|
|
|
|
|